# Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death

> **NCT01360047** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 39513 (actual)

## Conditions studied

- Nonfatal Myocardial Infarction
- Coronary Death

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01360047
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 39513 (ACTUAL)
- **Last updated:** 2012-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01360047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01360047, "Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01360047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
